Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD: a Propensity-Matched Observational Study

Background and objectives: The severity of anemia at which to initiate erythropoiesis-stimulating agent (ESA) treatment in nondialysis chronic kidney disease (CKD) patients is unclear. Risk of mortality, hospitalizations, and blood transfusion were compared among nondialysis CKD patients with “early...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seliger, Stephen, Fox, Kathleen M., Gandra, Shravanthi R., Bradbury, Brian, Hsu, Van Doren, Walker, Loreen, Chiou, Chiun-Fang, Fink, Jeffrey C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Nephrology 2010
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2863974/
https://ncbi.nlm.nih.gov/pubmed/20299377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07171009
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge